Literature DB >> 1461348

Solvent effects on beta protein toxicity in vivo.

J Waite1, G M Cole, S A Frautschy, D J Connor, L J Thal.   

Abstract

Human beta (1-40) and rat beta (1-42) were dissolved in three different solvents and stereotaxically injected into rat hippocampus with the contralateral side injected with control reverse sequence peptide or vehicle alone. Results at 1 week showed gross toxicity of the 35% acetonitrile solvent which was markedly enhanced by 3 nmol of beta protein but not by reverse sequence peptide. Beta peptide in water also appeared more toxic than reverse sequence, but the results were less clear cut. In contrast, 3 nmol of beta peptide in a cyclodextrin/PBS solution produced no marked short-term toxic effects. Peripheral injection of substance P failed to prevent toxicity. We conclude that solvent effects play a major role in acute beta protein neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1461348     DOI: 10.1016/0197-4580(92)90062-3

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  10 in total

1.  Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide.

Authors:  C L Shen; G L Scott; F Merchant; R M Murphy
Journal:  Biophys J       Date:  1993-12       Impact factor: 4.033

2.  Amyloid beta-protein (Abeta) 1-40 but not Abeta1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain.

Authors:  R W Shin; K Ogino; A Kondo; T C Saido; J Q Trojanowski; T Kitamoto; J Tateishi
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

3.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons.

Authors:  D T Loo; A Copani; C J Pike; E R Whittemore; A J Walencewicz; C W Cotman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

4.  Use of copper and insulin-resistance to accelerate cognitive deficits and synaptic protein loss in a rat Abeta-infusion Alzheimer's disease model.

Authors:  Aynun N Begum; Fusheng Yang; Edmond Teng; Shuxin Hu; Mychica R Jones; Emily R Rosario; Walter Beech; Beverly Hudspeth; Oliver J Ubeda; Greg M Cole; Sally A Frautschy
Journal:  J Alzheimers Dis       Date:  2008-12       Impact factor: 4.472

5.  Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide.

Authors:  C L Shen; M C Fitzgerald; R M Murphy
Journal:  Biophys J       Date:  1994-09       Impact factor: 4.033

6.  Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths.

Authors:  S W Snyder; U S Ladror; W S Wade; G T Wang; L W Barrett; E D Matayoshi; H J Huffaker; G A Krafft; T F Holzman
Journal:  Biophys J       Date:  1994-09       Impact factor: 4.033

7.  Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain.

Authors:  S A Frautschy; D L Horn; J J Sigel; M E Harris-White; J J Mendoza; F Yang; T C Saido; G M Cole
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

8.  Per-6-substituted beta-cyclodextrin libraries inhibit formation of beta-amyloid-peptide (A beta)-derived, soluble oligomers.

Authors:  Jiaxin Yu; Lara Bakhos; Lei Chang; Mark J Holterman; William L Klein; Duane L Venton
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

Review 9.  Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (aβ) self-assembly.

Authors:  Laramie P Jameson; Nicholas W Smith; Sergei V Dzyuba
Journal:  ACS Chem Neurosci       Date:  2012-08-06       Impact factor: 4.418

10.  Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss.

Authors:  Ariel E Reyes; Marcelo A Chacón; Margarita C Dinamarca; Waldo Cerpa; Carlos Morgan; Nibaldo C Inestrosa
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.